125 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

FRLN

Freeline Therapeutics Holdings
US$6.48-0.2%-21.7%US$28.3mUS$8.25PS45.4xE60.7%n/a

CELZ

Creative Medical Technology Holdings
US$5.53-0.5%13.3%US$7.5mUS$30.00PS833.6xE59.9%n/a

TARS

Tarsus Pharmaceuticals
US$35.21-1.8%186.3%US$1.3bUS$52.33PS75.7xE55.5%n/a

SGEN

Seagen
US$228.744.5%76.5%US$43.2bUS$228.91PS18.8xE71.8%n/a

TBPH

Theravance Biopharma
US$9.474.9%-14.1%US$452.1mUS$14.00PS8xE56.8%n/a

CYCC

Cyclacel Pharmaceuticals
US$2.112.9%-76.8%US$2.8mUS$163.00PS6.6xE56.6%n/a

SRRA

Sierra Oncology
US$54.990.06%179.4%US$1.3bUS$55.00PB5.1xE69.5%n/a

ORGO

Organogenesis Holdings
US$2.976.1%39.4%US$373.5mUS$4.83PE79.3xE46.4%n/a

ATOS

Atossa Therapeutics
US$1.75-12.5%148.1%US$234.3mUS$4.58PB2.4xE66.2%n/a

SLNO

Soleno Therapeutics
US$40.31-2.8%1,545.3%US$1.4bUS$64.33PB8.3xE60.3%n/a

CKPT

Checkpoint Therapeutics
US$1.82-9.9%-23.0%US$65.3mUS$17.25PS630.6xE88.1%n/a

OLK

Olink Holding
US$23.24-1.1%4.2%US$2.9bUS$26.00PS17xE61.0%n/a

CTXR

Citius Pharmaceuticals
US$0.96-6.7%-34.2%US$159.0mUS$4.00PB1.8xE62.7%n/a

PBH

Prestige Consumer Healthcare
US$68.63-4.3%8.2%US$3.4bUS$74.33PS3xE34.5%n/a

NBY

NovaBay Pharmaceuticals
US$0.092-12.2%-94.2%US$3.0mUS$3.35PB2xE130.1%n/a

RVTY

Revvity
US$106.413.0%-19.9%US$12.6bUS$123.11PE73.2xE24.1%0.3%

IMGN

ImmunoGen
US$31.236.6%617.9%US$8.4bUS$28.95PS29.1xE45.8%n/a

ELAN

Elanco Animal Health
US$15.48-3.1%69.2%US$7.7bUS$17.24PS1.7xE91.3%n/a

PRPH

ProPhase Labs
US$6.60-3.6%-22.4%US$122.7mUS$20.00PS2.7xE67.1%0%

CBST.F

Cannabist Company Holdings
US$0.361.1%-28.1%US$164.9mUS$1.03PB2.5xE94.2%n/a

IMUX

Immunic
US$1.29-5.1%-3.0%US$115.1mUS$7.38PB4xE57.8%n/a

MGTX

MeiraGTx Holdings
US$5.57-4.1%4.7%US$353.2mUS$21.60PS25.5xE52.8%n/a

SAVA

Cassava Sciences
US$23.5716.2%2.0%US$921.6mUS$124.00PB7.4xE104.9%n/a

AVTR

Avantor
US$25.671.7%21.9%US$17.6bUS$27.48PE54.3xE27.2%n/a
Page 5 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.